Since FRZB antagonizes Wnt signaling through competitive binding to Wnt ligands12,13, we investigated the downstream signal transducer, β-catenin, and observed strikingly increased immunoreactivity in myofibers of ALS muscle sections, predominantly localized to the muscle membrane. The gene discussed is FRZB; the disease is amyotrophic lateral sclerosis.